发明申请
- 专利标题: COMPOUNDS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
- 专利标题(中): 用于治疗神经病学症状的化合物
-
申请号: US13140694申请日: 2009-12-18
-
公开(公告)号: US20120046283A1公开(公告)日: 2012-02-23
- 发明人: David Campbell , Sergio G. Durón , Benedikt Vollrath , Warren Wade
- 申请人: David Campbell , Sergio G. Durón , Benedikt Vollrath , Warren Wade
- 申请人地址: US CA LA JOLLA
- 专利权人: AFRAXIS INC.
- 当前专利权人: AFRAXIS INC.
- 当前专利权人地址: US CA LA JOLLA
- 优先权: US61139477 20081219; US61139498 20081219; US61250262 20091009; US61286317 20091214
- 国际申请: PCT/US09/68855 WO 20091218
- 主分类号: A61K31/5377
- IPC分类号: A61K31/5377 ; A61P25/18 ; A61K31/519 ; C07D471/04 ; A61K31/496
摘要:
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of neuropsychiatric conditions.
公开/授权文献
- US08674095B2 Compounds for treating neuropsychiatric conditions 公开/授权日:2014-03-18